• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ETHICON INC. PROLIFT PELVIC FLOOR REPAIR UNKNOWN PRODUCT; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ETHICON INC. PROLIFT PELVIC FLOOR REPAIR UNKNOWN PRODUCT; MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Erosion (1750); Cellulitis (1768); Hemorrhage/Bleeding (1888); Incontinence (1928); Unspecified Infection (1930); Pain (1994); Urinary Tract Infection (2120)
Event Date 01/01/2012
Event Type  Injury  
Manufacturer Narrative
Product complaint# (b)(4).This report is related to a journal article; therefore, no product will be returned for analysis and the batch history records cannot be reviewed as the lot number has not been provided.  the single complaint was reported with multiple events.There are no additional details regarding the additional events.  citation: international urogynecology journal and pelvic floor dysfunction.2012 sep.23 (2 suppl.1): s203-s204.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.Event related to prolift device reported via mw # 2210968-2021-02936.Event related to gynecare mesh reported via mw # 2210968-2021-02937.Event related to prollene suture reported via mw # 2210968-2021-02938.
 
Event Description
It was reported in a journal article with title: transvaginal mesh for pelvic organ prolapse: 10-year experience with 627 procedures.The objective of this retrospective cohort study was to evaluate and compare the outcomes of three different transvaginal mesh (tvm) procedures for pelvic organ prolapse.Between january 2002 and april 2012, a total of 672 (average age=61.2 years, age range=31 ¿ 87 years) tvm procedures were performed.The patients were divided into three groups: 76 with gynemesh, 299 with prolift, and 248 with elevate.During the procedure, an anterior and/or posterior vaginal repair with a surgeon fashioned inlay of gynemesh (ethicon, inc., a knitted, large-pore, monofilament polypropylene mesh of 41g/m2 density), with or without concurrent ssf using 0-prolene suture (ethicon) (referred to as the 'gynemesh' group hereafter); an anterior, posterior or total prolift, (ethicon, inc., a kit utilizing gynemesh in a trocar-based delivery system, with 4 exits anteriorly and 2 exits posteriorly, providing apical support via bilateral sacrospinous ligament fixation (ssf) with the posterior and total systems, the 'prolift' group); or an anterior and/or posterior elevate (american medical systems, inc., a kit using intepro litetm mesh, a polypropylene mesh of 25 g/m2 density, in a trocar-less, no exit system, designed with self-fixating tips, allowing bilateral ssf with both the anterior as well as the posterior systems, the 'elevate' group).Reported complications in prolift group included longer time (mean difference 15 mins, p<0.001) and had greater number of intraoperative bleeding complications (defined as an estimated blood loss of >=500 cc, a hemoglobin drop of >=30 g/l, or the need for blood transfusion, 15.3% vs 7.4%, p=0.009) compared to the other groups (n=?); cystotomies (n=4); urinary tract infection and transient voiding dysfunction resulted in 5.1% (n=?); suffered more febrile episodes (5.4% vs 1.2%, p=0.014) (n=?); exit-site cellulitis (3.0%) (n=?); mesh complications, such as erosion, contraction causing stenosis, and prominence (n=?); de novo stress urinary incontinence, urge incontinence, and dyspareunia (n=?).Reported complications in gynemesh group included intraoperative bleeding complications (defined as an estimated blood loss of >=500 cc, a hemoglobin drop of >=30 g/l, or the need for blood transfusion, 15.3% vs 7.4%, p=0.009) (n=?); infection (n=?) requiring surgical debridement and removal of the mesh implant; mesh complications, such as erosion, contraction causing stenosis, and prominence (n=?); de novo stress urinary incontinence, urge incontinence, and dyspareunia (n=?).In conclusion, the study suggest that while elevate and prolift tvm kits are associated with improved anatomical cure rates over the surgeon-fashioned gynemesh inlay, - the trocar ¿ based system, which requires greater dissection and has exit sites, is associated with greater operative morbidity, and complications such as mesh erosion and contraction appear to be related to the specific mesh used, indicating that differences in mesh properties, such as density, could account for differences in these complication rates.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PROLIFT PELVIC FLOOR REPAIR UNKNOWN PRODUCT
Type of Device
MESH, SURGICAL, SYNTHETIC, UROGYNECOLOGIC
Manufacturer (Section D)
ETHICON INC.
p.o. box 151, route 22 west
somerville NJ 08876
Manufacturer (Section G)
ETHICON SARL-NEUCHATEL
puits-godet 20
neuchatel 2000
SZ   2000
Manufacturer Contact
elba bello
p.o. box 151, route 22 west
somerville, NJ 08876
9082182213
MDR Report Key11602575
MDR Text Key243637271
Report Number2210968-2021-02936
Device Sequence Number1
Product Code OTP
Combination Product (y/n)N
Reporter Country CodeAS
PMA/PMN Number
K013718
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,l
Reporter Occupation Other
Type of Report Initial
Report Date 03/02/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator No Information
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 03/02/2021
Initial Date FDA Received04/01/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-